A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNß drugs in the treatment of multiple sclerosis.

Human molecular genetics

Harari D, Orr I, Rotkopf R, Baranzini SE, Schreiber G. A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNß drugs in the treatment of multiple sclerosis. Hum Mol Genet. 2015 Jun 01; 24(11):3192-205.

2015
https://researcherprofiles.org/profile/1189582
25721402

Harari D, Orr I, Rotkopf R, Baranzini SE, Schreiber G